Therefore, ASP4021 likely competes against Ang2, a natural antagonist of Tie2 that is involved in vascular leakage and abnormal vessel structure and is elevated in the plasma of diabetic retinopathy patients8, making it a potential therapeutic target for retinal disease. The gene discussed is TEK; the disease is diabetic retinopathy.